Neuroblastoma (NBL), the most frequent and lethal pediatric cancer of children in pre-school
age, is considered enigmatic in view of its extreme heterogeneity, from spontaneous …

Neuroblastoma is one of the few childhood cancers that carries a tumor-specific antigen in
the form of a glycolipid antigen known as GD2. It has restricted expression in normal tissue …

Neuroblastoma (NBL) is the most common extracranial solid tumor in pediatrics, yet overall
survival is poor for high-risk cases. Immunotherapy regimens using a tumor-selective …

Neuroblastoma is the most common extracranial solid tumor in children. Although low-risk
neuroblastoma is mostly curable, the outcome of high-risk neuroblastoma, which …

Neuroblastoma is a pediatric solid cancer of heterogeneous clinical behavior. The unique
features of this type of cancer frequently hamper the process of determining clinical …

Introduction: Current therapeutic approaches for high-risk neuroblastoma (HR-NB) include
high-dose chemotherapy, surgery and radiotherapy; interventions that are associated with …

Neuroblastoma (NB) with various clinical presentation is a known childhood malignancy.
Despite significant progress in treatment of NB afflicted patients, high risk disease is usually …

While the adoption of multimodal therapy including surgery, radiation, and aggressive
combination chemotherapy has improved outcomes for many children with high-risk …

Simple Summary Molecular analyses discussed in Molecular Tumor Boards are expected to
improve cancer treatment by identifying tumor-specific alterations. Here, we quantified the …

Neuroblastoma (NB) is the most common extracranial solid tumor of childhood. The majority
of children suffers from high risk neuroblastoma and has disseminated disease at the time of …